Cargando…
Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study
BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experienc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408632/ https://www.ncbi.nlm.nih.gov/pubmed/37560578 http://dx.doi.org/10.25259/SNI_411_2023 |
_version_ | 1785086205796286464 |
---|---|
author | Reddy, Vyjayanth Pradhan, Aseem Prasad, G. Lakshmi Menon, Girish |
author_facet | Reddy, Vyjayanth Pradhan, Aseem Prasad, G. Lakshmi Menon, Girish |
author_sort | Reddy, Vyjayanth |
collection | PubMed |
description | BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experience in the management, outcomes, and prognostic factors of TBGH. METHODS: A 4-year retrospective study which included all cases of TBGH, except dot contusions (<2 mL) and those with coagulopathies. Admission variables were correlated with Glasgow Outcome Scale score at discharge and 12 months. RESULTS: Thirty-two patients were analyzed. The mean age was 39.2 years. Two-thirds were due to road traffic accidents. Around 60% were severe head injuries. The mean Glasgow coma scale (GCS) score at presentation was 8.5. Twenty patients had moderate-to-severe hemiparesis. The mean hematoma volume was 18.1 mL. Associated traumatic intracranial lesions were seen in 28 cases. Only 7 patients (22%) underwent surgery. The mean follow-up was 17.4 months (range 14–34 months). The mortality rate was 12.5% (n = 4). Among the survivors, only 39% (n = 11) had good outcomes at discharge which showed modest improvement to 54% (n = 15) at 12 months. CONCLUSION: Our study noted that poor admission GCS scores, poor motor response, presence of significant hemiparesis, and larger hematoma volumes (>20 mL) correlated with poor outcomes at 12 months. The overall outcomes have been mostly unfavorable as observed in majority of studies due to deeper location of these hematomas, high proportion of severe head injuries, and high proportion of residual weakness in survivors. |
format | Online Article Text |
id | pubmed-10408632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-104086322023-08-09 Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study Reddy, Vyjayanth Pradhan, Aseem Prasad, G. Lakshmi Menon, Girish Surg Neurol Int Original Article BACKGROUND: Traumatic basal ganglia hematomas (TBGH) are rare entities. They are situated in the deep cerebral parenchyma and have also been termed as intermediate coup contusions. Available literature is sparse with regards to the characteristics and prognosis of TBGH. We aim to share our experience in the management, outcomes, and prognostic factors of TBGH. METHODS: A 4-year retrospective study which included all cases of TBGH, except dot contusions (<2 mL) and those with coagulopathies. Admission variables were correlated with Glasgow Outcome Scale score at discharge and 12 months. RESULTS: Thirty-two patients were analyzed. The mean age was 39.2 years. Two-thirds were due to road traffic accidents. Around 60% were severe head injuries. The mean Glasgow coma scale (GCS) score at presentation was 8.5. Twenty patients had moderate-to-severe hemiparesis. The mean hematoma volume was 18.1 mL. Associated traumatic intracranial lesions were seen in 28 cases. Only 7 patients (22%) underwent surgery. The mean follow-up was 17.4 months (range 14–34 months). The mortality rate was 12.5% (n = 4). Among the survivors, only 39% (n = 11) had good outcomes at discharge which showed modest improvement to 54% (n = 15) at 12 months. CONCLUSION: Our study noted that poor admission GCS scores, poor motor response, presence of significant hemiparesis, and larger hematoma volumes (>20 mL) correlated with poor outcomes at 12 months. The overall outcomes have been mostly unfavorable as observed in majority of studies due to deeper location of these hematomas, high proportion of severe head injuries, and high proportion of residual weakness in survivors. Scientific Scholar 2023-07-21 /pmc/articles/PMC10408632/ /pubmed/37560578 http://dx.doi.org/10.25259/SNI_411_2023 Text en Copyright: © 2023 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Reddy, Vyjayanth Pradhan, Aseem Prasad, G. Lakshmi Menon, Girish Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title | Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title_full | Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title_fullStr | Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title_full_unstemmed | Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title_short | Clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: A 4-year single-center study |
title_sort | clinical outcomes and prognostic factors of traumatic basal ganglia hematomas: a 4-year single-center study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408632/ https://www.ncbi.nlm.nih.gov/pubmed/37560578 http://dx.doi.org/10.25259/SNI_411_2023 |
work_keys_str_mv | AT reddyvyjayanth clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy AT pradhanaseem clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy AT prasadglakshmi clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy AT menongirish clinicaloutcomesandprognosticfactorsoftraumaticbasalgangliahematomasa4yearsinglecenterstudy |